- Home
- EPSM vs RXST Comparison
EPSM vs RXST Comparison
Compare EPSM & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPSM
- RXST
- Stock Information
- Founded
- EPSM 2010
- RXST 1997
- Country
- EPSM China
- RXST United States
- Employees
- EPSM N/A
- RXST N/A
- Industry
- EPSM
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- EPSM
- RXST Health Care
- Exchange
- EPSM Nasdaq
- RXST Nasdaq
- Market Cap
- EPSM 467.5M
- RXST 385.0M
- IPO Year
- EPSM 2025
- RXST 2021
- Fundamental
- Price
- EPSM $30.28
- RXST $8.28
- Analyst Decision
- EPSM
- RXST Hold
- Analyst Count
- EPSM 0
- RXST 11
- Target Price
- EPSM N/A
- RXST $11.80
- AVG Volume (30 Days)
- EPSM 1.1M
- RXST 784.0K
- Earning Date
- EPSM 11-24-2025
- RXST 11-06-2025
- Dividend Yield
- EPSM N/A
- RXST N/A
- EPS Growth
- EPSM N/A
- RXST N/A
- EPS
- EPSM 0.02
- RXST N/A
- Revenue
- EPSM $12,518,070.00
- RXST $147,059,000.00
- Revenue This Year
- EPSM N/A
- RXST N/A
- Revenue Next Year
- EPSM N/A
- RXST $6.71
- P/E Ratio
- EPSM $1,505.84
- RXST N/A
- Revenue Growth
- EPSM N/A
- RXST 27.68
- 52 Week Low
- EPSM $4.23
- RXST $6.32
- 52 Week High
- EPSM $155.00
- RXST $55.57
- Technical
- Relative Strength Index (RSI)
- EPSM N/A
- RXST 40.62
- Support Level
- EPSM N/A
- RXST $8.55
- Resistance Level
- EPSM N/A
- RXST $9.38
- Average True Range (ATR)
- EPSM 0.00
- RXST 0.45
- MACD
- EPSM 0.00
- RXST -0.11
- Stochastic Oscillator
- EPSM 0.00
- RXST 4.08
About EPSM Epsium Enterprise Limited Ordinary Shares
Epsium Enterprise Ltd is a holding company and conducts business through its subsidiaries. It is engaged in import trading and wholesale selling of beverages in Macau. The company imports and sells a range of beverages, alcoholic beverages, and a small quantity of tea and fruit juice. The alcoholic beverages it sells include Chinese liquor, French cognac, Scottish whiskey, fine wine, Champagne, and other miscellaneous beverage alcohol.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.